SomaLogic Q2 EPS $(0.13) Beats $(0.16) Estimate, Sales $20.47M Beat $19.82M Estimate

SomaLogic (NASDAQ: SLGC) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.16) by 18.75 percent. This is unchanged from the same period last year. The company reported quarterly sales of $20.47 million which beat the analyst consensus estimate of $19.82 million by 3.27 percent. This is a 44.71 percent increase over sales of $14.14 million the same period last year.